Biotensegrity of the extracellular matrix: Physiology, dynamic mechanical balance, and implications in oncology and mechanotherapy

Frontiers in Oncology

Volumn 4 MAR, Issue , 2014, Pages

  Tadeo, Irene ^a   Berbegall, Ana P ^a,b   Escudero, Luis M ^c   Álvaro, Tomás ^d   Noguera, Rosa ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d Hospital de Tortosa   (Spain)

Author keywords

Biotensegrity; Cancer; Extracellular matrix; Mechanotherapy; Neuroblastoma

Indexed keywords

CD31 ANTIGEN; CD45 ANTIGEN; COLLAGEN; FIBRONECTIN; INTEGRIN; LAMININ; LAMININ 1; MATRIX METALLOPROTEINASE; TENASCIN; TOLL LIKE RECEPTOR 9; UVOMORULIN;

ACTIN FILAMENT; APOPTOSIS; BIOTENSEGRITY; CANCER GROWTH; CELL DIFFERENTIATION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; EPIGENETICS; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MECHANOTRANSDUCTION; METASTASIS; NEUROBLASTOMA; PHYSICAL PARAMETERS; REVIEW; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84901020248     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00039     Document Type: Review

References (88)

1. Fuller RB. Tensegrity. Portfolio Art News Annu (1961) 4:112-27.
2. Fuller RB. Tensile-Integrity Structures. United States patent 3063521 (1962).
3. Galli C, Guizzardi S, Passeri G, Macaluso GM, Scandroglio R. Life on the wire: on tensegrity and force balance in cells. Acta Biomed (2005) 76(1):5-12.
4. Ingber DE. The architecture of life. Sci Am (1998) 278(1):48-57. doi: 10.1038/scientificamerican0198-48.
5. Ingber DE. Tensegrity-based mechanosensing from macro to micro. Prog Biophys Mol Biol (2008) 97(2-3):163-79. doi:10.1016/j.pbiomolbio.2008.02.005.
6. Hu S, Chen J, Wang N. Cell spreading controls balance of prestress by microtubules and extracellular matrix. Front Biosci (2004) 9:2177-82. doi:10.2741/1352.
7. Ingber DE. Tensegrity II. How structural networks influence cellular information processing networks. J Cell Sci (2003) 116(Pt 8):1397-408. doi:10.1242/jcs.00360.
8. Ingber DE. Tensegrity I. Cell structure and hierarchical systems biology. J Cell Sci (2003) 116(Pt 7):1157-73. doi:10.1242/jcs.00359.
9. Laurent VM, Canadas P, Fodil R, Planus E, Asnacios A, Wendling S, et al. Tensegrity behaviour of cortical and cytosolic cytoskeletal components in twisted living adherent cells. Acta Biotheor (2002) 50(4):331-56. doi:10.1023/A:1022676903680.
10. Stamenovic D, Mijailovich SM, Tolic-Norrelykke IM, Chen J, Wang N. Cell prestress. II. Contribution of microtubules. Am J Physiol Cell Physiol (2002) 282(3):C617-24. doi:10.1152/ajpcell.00271.2001.
11. Stamenovic D, Mijailovich SM, Tolic-Norrelykke IM, Wang N. Experimental tests of the cellular tensegrity hypothesis. Biorheology (2003) 40(1-3):221-5.
12. Volokh KY, Vilnay O, Belsky M. Tensegrity architecture explains linear stiffening and predicts softening of living cells. J Biomech (2000) 33(12):1543-9. doi:10.1016/S0021-9290(00)00157-3.
13. Wang N, Naruse K, Stamenovic D, Fredberg JJ, Mijailovich SM, Tolic-Norrelykke IM, et al. Mechanical behavior in living cells consistent with the tensegrity model. Proc Natl Acad Sci U S A (2001) 98(14):7765-70. doi:10.1073/pnas.141199598.
14. Wang N, Tolic-Norrelykke IM, Chen J, Mijailovich SM, Butler JP, Fredberg JJ, et al. Cell prestress. I. Stiffness and prestress are closely associated in adherent contractile cells. Am J Physiol Cell Physiol (2002) 282(3):C606-16. doi:10.1152/ajpcell.00269.2001.
15. Ross TD, Coon BG, Yun S, Baeyens N, Tanaka K, Ouyang M, et al. Integrins in mechanotransduction. Curr Opin Cell Biol (2013) 25(5):613-8. doi:10.1016/j.ceb.2013.05.006.
16. Chen CS. Mechanotransduction-a field pulling together? J Cell Sci (2008) 121(Pt 20):3285-92. doi:10.1242/jcs.023507.
17. Luxton GW, Gomes ER, Folker ES, Vintinner E, Gundersen GG. Linear arrays of nuclear envelope proteins harness retrograde actin flow for nuclear movement. Science (2010) 329(5994):956-9. doi:10.1126/science.1189072.
18. Morgan JT, Pfeiffer ER, Thirkill TL, Kumar P, Peng G, Fridolfsson HN, et al. Nesprin-3 regulates endothelial cell morphology, perinuclear cytoskeletal architecture, and flow-induced polarization. Mol Biol Cell (2011) 22(22):4324-34. doi:10.1091/mbc.E11-04-0287.
19. Ketema M, Sonnenberg A. Nesprin-3: a versatile connector between the nucleus and the cytoskeleton. Biochem Soc Trans (2011) 39(6):1719-24. doi:10.1042/BST20110669.
20. Tapley EC, Starr DA. Connecting the nucleus to the cytoskeleton by SUN-KASH bridges across the nuclear envelope. Curr Opin Cell Biol (2013) 25(1):57-62. doi:10.1016/j.ceb.2012.10.014.
21. Lombardi ML, Jaalouk DE, Shanahan CM, Burke B, Roux KJ, Lammerding J. The interaction between nesprins and sun proteins at the nuclear envelope is critical for force transmission between the nucleus and cytoskeleton. J Biol Chem (2011) 286(30):26743-53. doi:10.1074/jbc.M111.233700.
22. Roux KJ, Crisp ML, Liu Q, Kim D, Kozlov S, Stewart CL, et al. Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-mediated cell polarization. Proc Natl Acad Sci U S A (2009) 106(7):2194-9. doi:10.1073/pnas.0808602106.
23. Swift J, Ivanovska IL, Buxboim A, Harada T, Dingal PC, Pinter J, et al. Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation. Science (2013) 341(6149):1240104. doi:10.1126/science.1240104.
24. Liu Z, Tan JL, Cohen DM, Yang MT, Sniadecki NJ, Ruiz SA, et al. Mechanical tugging force regulates the size of cell-cell junctions. Proc Natl Acad Sci U S A (2010) 107(22):9944-9. doi:10.1073/pnas.0914547107.
25. Maruthamuthu V, Sabass B, Schwarz US, Gardel ML. Cell-ECM traction force modulates endogenous tension at cell-cell contacts. Proc Natl Acad Sci U S A (2011) 108(12):4708-13. doi:10.1073/pnas.1011123108.
26. le Duc Q, Shi Q, Blonk I, Sonnenberg A, Wang N, Leckband D, et al. Vinculin potentiates E-cadherin mechanosensing and is recruited to actin-anchored sites within adherens junctions in a myosin II-dependent manner. J Cell Biol (2010) 189(7):1107-15. doi:10.1083/jcb.201001149.
27. Twiss F, de Rooij J. Cadherin mechanotransduction in tissue remodeling. Cell Mol Life Sci (2013) 70(21):4101-16. doi:10.1007/s00018-013-1329-x.
28. Huang S, Ingber DE. The structural and mechanical complexity of cell-growth control. Nat Cell Biol (1999) 1(5):E131-8. doi:10.1038/13043.
29. Schwarz US. Catch me because you can: a mathematical model for mechanosensing. Biophys J (2013) 105(6):1289-91. doi:10.1016/j.bpj.2013.08.016.
30. Benoit YD, Lussier C, Ducharme PA, Sivret S, Schnapp LM, Basora N, et al. Integrin alpha8beta1 regulates adhesion, migration and proliferation of human intestinal crypt cells via a predominant RhoA/ROCK-dependent mechanism. Biol Cell (2009) 101(12):695-708. doi:10.1042/BC20090060.
31. Zargham R. Tensegrin in context: dual role of alpha8 integrin in the migration of different cell types. Cell Adh Migr (2010) 4(4):485-90. doi:10.4161/cam.4.4.12403.
32. Kim SH, Turnbull J, Guimond S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol (2011) 209(2):139-51. doi:10.1530/JOE-10-0377.
33. Mustata T, Rusu V. Mechanotransduction and tensegrity (I). Rev Med Chir Soc Med Nat Iasi (1998) 102(3-4):25-35.
34. Noguera R, Nieto OA, Tadeo I, Farinas F, Alvaro T. Extracellular matrix, biotensegrity and tumor microenvironment. An update and overview. Histol Histopathol (2012) 27(6):693-705.
35. Huang C, Miyazaki K, Akaishi S, Watanabe A, Hyakusoku H, Ogawa R. Biological effects of cellular stretch on human dermal fibroblasts. J Plast Reconstr Aesthet Surg (2013) 66(12):e351-61. doi:10.1016/j.bjps.2013.08.002.
36. Lovett DB, Shekhar N, Nickerson JA, Roux KJ, Lele TP. Modulation of nuclear shape by substrate rigidity. Cell Mol Bioeng (2013) 6(2):230-8. doi:10.1007/s12195-013-0270-2.
37. Duncan RL, Turner CH. Mechanotransduction and the functional response of bone to mechanical strain. Calcif Tissue Int (1995) 57(5):344-58. doi:10.1007/BF00302070.
38. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell (2006) 126(4):677-89. doi:10.1016/j.cell.2006.06.044.
39. Lo CM, Wang HB, Dembo M, Wang YL. Cell movement is guided by the rigidity of the substrate. Biophys J (2000) 79(1):144-52. doi:10.1016/S0006-3495(00)76279-5.
40. Zou X, Feng B, Dong T, Yan G, Tan B, Shen H, et al. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis. J Proteomics (2013) 94:473-85. doi:10.1016/j.jprot.2013.10.020.
41. Tlsty TD. Stromal cells can contribute oncogenic signals. Semin Cancer Biol (2001) 11(2):97-104. doi:10.1006/scbi.2000.0361.
42. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol (2006) 1:119-50. doi:10.1146/annurev.pathol.1.110304.100224.
43. Pupa SM, Menard S, Forti S, Tagliabue E. New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol (2002) 192(3):259-67. doi:10.1002/jcp.10142.
44. Dityatev A, Schachner M, Sonderegger P. The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat Rev Neurosci (2010) 11(11):735-46. doi:10.1038/nrn2898.
45. Liu H, Tang L. Mechano-regulation of alternative splicing. Curr Genomics (2013) 14(1):49-55. doi:10.2174/138920213804999156.
46. Plotnikov SV, Waterman CM. Guiding cell migration by tugging. Curr Opin Cell Biol (2013) 25(5):619-26. doi:10.1016/j.ceb.2013.06.003.
47. Smith HW, Marshall CJ. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol (2010) 11(1):23-36. doi:10.1038/nrm2821.
48. Ingber DE. Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation (2002) 70(9-10):547-60. doi:10.1046/j.1432-0436.2002.700908.x.
49. Huang S, Ingber DE. A non-genetic basis for cancer progression and metastasis: self-organizing attractors in cell regulatory networks. Breast Dis (2006) 26:27-54.
50. Tadeo I, Piqueras M, Montaner D, Villamon E, Berbegall AP, Canete A, et al. Quantitative modeling of clinical, cellular and extracellular matrix variables suggest prognostic indicators in cancer. A model in neuroblastoma. Pediatr Res (2013) 75(2):302-14. doi:10.1038/pr.2013.217.
51. DuFort CC, Paszek MJ, Weaver VM. Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol (2010) 12(5):308-19. doi:10.1038/nrm3112.
52. Pathak A, Kumar S. Independent regulation of tumor cell migration by matrix stiffness and confinement. Proc Natl Acad Sci U S A (2012) 109(26):10334-9. doi:10.1073/pnas.1118073109.
53. Cross SE, Jin YS, Rao J, Gimzewski JK. Nanomechanical analysis of cells from cancer patients. Nat Nanotechnol (2007) 2(12):780-3. doi:10.1038/nnano.2007.388.
54. Lekka M, Laidler P, Gil D, Lekki J, Stachura Z, Hrynkiewicz AZ. Elasticity of normal and cancerous human bladder cells studied by scanning force microscopy. Eur Biophys J (1999) 28(4):312-6. doi:10.1007/s002490050213.
55. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology (2007) 39(3):305-18. doi:10.1080/00313020701329914.
56. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol (2006) 172(7):973-81. doi:10.1083/jcb.200601018.
57. Suresh S. Biomechanics and biophysics of cancer cells. Acta Biomater (2007) 3(4):413-38. doi:10.1016/j.actbio.2007.04.002.
58. Blick T, Widodo E, Hugo H, Waltham M, Lenburg ME, Neve RM, et al. Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis (2008) 25(6):629-42. doi:10.1007/s10585-008-9170-6.
59. Kenny PA, Bissell MJ. Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer (2003) 107(5):688-95. doi:10.1002/ijc.11491.
60. Vassy J, Portet S, Beil M, Millot G, Fauvel-Lafeve F, Gasset G, et al. Weightlessness acts on human breast cancer cell line MCF-7. Adv Space Res (2003) 32(8):1595-603. doi:10.1016/S0273-1177(03)90400-5.
61. Mierke CT. Physical break-down of the classical view on cancer cell invasion and metastasis. Eur J Cell Biol (2013) 92(3):89-104. doi:10.1016/j.ejcb.2012.12.002.
62. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer (1999) 86(2):364-72. doi:10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7.
63. Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med (2012) 18(9):1359-68. doi:10.1038/nm.2890.
64. Sun Y, Nelson PS. Molecular pathways: involving microenvironment damage responses in cancer therapy resistance. Clin Cancer Res (2012) 18(15):4019-25. doi:10.1158/1078-0432.CCR-11-0768.
65. Choi IK, Strauss R, Richter M, Yun CO, Lieber A. Strategies to increase drug penetration in solid tumors. Front Oncol (2013) 3:193. doi:10.3389/fonc.2013.00193.
66. Cukierman E, Bassi DE. The mesenchymal tumor microenvironment: a drug-resistant niche. Cell Adh Migr (2012) 6(3):285-96. doi:10.4161/cam.20210.
67. Pritchard JR, Gilbert LA, Meacham CE, Ricks JL, Jiang H, Lauffenburger DA, et al. Bcl-2 family genetic profiling reveals microenvironment-specific determinants of chemotherapeutic response. Cancer Res (2011) 71(17):5850-8. doi:10.1158/0008-5472.CAN-11-1014.
68. Aguilar-Cuenca R, Juanes-Garcia A, Vicente-Manzanares M. Myosin II in mechanotransduction: master and commander of cell migration, morphogenesis, and cancer. Cell Mol Life Sci (2013) 71(3):479-92. doi:10.1007/s00018-013-1439-5.
69. Álvaro Naranjo T, Noguera Salvá R, Fariñas Guerrero F. Extracellular matrix: morphology, function and biotensegrity (part I). Rev Esp Patol (2009) 42(4):249-61.
70. Álvaro Naranjo T, Noguera Salvá R, Fariñas Guerrero F. The extracellular matrix: from the molecular mechanics to the tumoral microenvironment (part II). Rev Esp Patol (2010) 43(1):24-32.
71. Negaard HF, Svennevig K, Kolset SO, Iversen N, Lothe IM, Ostenstad B, et al. Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas. Leuk Lymphoma (2009) 50(6):998-1004. doi:10.1080/10428190902889270.
72. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol (2009) 27(2):289-97. doi:10.1200/JCO.2008.16.6785.
73. Schleiermacher G, Janoueix-Lerosey I, Ribeiro A, Klijanienko J, Couturier J, Pierron G, et al. Accumulation of segmental alterations determines progression in neuroblastoma. J Clin Oncol (2010) 28(19):3122-30. doi:10.1200/JCO.2009.26.7955.
74. Schleiermacher G, Mosseri V, London WB, Maris JM, Brodeur GM, Attiyeh E, et al. Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Br J Cancer (2012) 107(8):1418-22. doi:10.1038/bjc.2012.375.
75. Escudero LM, Costa Lda F, Kicheva A, Briscoe J, Freeman M, Babu MM. Epithelial organisation revealed by a network of cellular contacts. Nat Commun (2011) 2:526. doi:10.1038/ncomms1536.
76. Saez A, Acha B, Montero-Sanchez A, Rivas E, Escudero LM, Serrano C. Neuromuscular disease classification system. J Biomed Opt (2013) 18(6):066017. doi:10.1117/1.JBO.18.6.066017.
77. Saez A, Rivas E, Montero-Sanchez A, Paradas C, Acha B, Pascual A, et al. Quantifiable diagnosis of muscular dystrophies and neurogenic atrophies through network analysis. BMC Med (2013) 11:77. doi:10.1186/1741-7015-11-77.
78. Sanchez-Gutierrez D, Saez A, Pascual A, Escudero LM. Topological progression in proliferating epithelia is driven by a unique variation in polygon distribution. PLoS One (2013) 8(11):e79227. doi:10.1371/journal.pone.0079227.
79. Csikasz-Nagy A, Escudero LM, Guillaud M, Sedwards S, Baum B, Cavaliere M. Cooperation and competition in the dynamics of tissue architecture during homeostasis and tumorigenesis. Semin Cancer Biol (2013) 23(4):293-8. doi:10.1016/j.semcancer.2013.05.009.
80. Guillaud M, Clem C, Macaulay C. An in silico platform for the study of epithelial pre-invasive neoplastic development. Biosystems (2010) 102(1):22-31. doi:10.1016/j.biosystems.2010.07.008.
81. Johnson LM, Price DK, Figg WD. Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy: implications for potential use of inhibitors in cancer treatment. Cancer Biol Ther (2013) 14(2):90-1. doi:10.4161/cbt.22636.
82. Ramsay AG, Clear AJ, Kelly G, Fatah R, Matthews J, Macdougall F, et al. Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy. Blood (2009) 114(21):4713-20. doi:10.1182/blood-2009-04-217687.
83. Pupa SM, Giuffre S, Castiglioni F, Bertola L, Cantu M, Bongarzone I, et al. Regulation of breast cancer response to chemotherapy by fibulin-1. Cancer Res (2007) 67(9):4271-7. doi:10.1158/0008-5472.CAN-06-4162.
84. Triulzi T, Ratti M, Tortoreto M, Ghirelli C, Aiello P, Regondi V, et al. Maspin influences response to doxorubicin by changing the tumor microenvironment organization. Int J Cancer (2013). doi:10.1002/ijc.28608.
85. Gao C, Kozlowska A, Nechaev S, Li H, Zhang Q, Hossain DM, et al. TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiation therapy. Cancer Res (2013) 73(24):7211-21. doi:10.1158/0008-5472.CAN-13-1314.
86. Jodele S, Blavier L, Yoon JM, DeClerck YA. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev (2006) 25(1):35-43. doi:10.1007/s10555-006-7887-8.
87. Sabbah M, Emami S, Redeuilh G, Julien S, Prevost G, Zimber A, et al. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat (2008) 11(4-5):123-51. doi:10.1016/j.drup.2008.07.001.
88. Raymond E, Dalgleish A, Damber JE, Smith M, Pili R. Mechanisms of action of tasquinimod on the tumour microenvironment. Cancer Chemother Pharmacol (2013) 73(1):1-8. doi:10.1007/s00280-013-2321-8.